News
5h
Investor's Business Daily on MSNArcutis Stock Awaits Next Move In A Base; Its Skin Drug Sales Grew 196%On May 6, Arcutis reported first-quarter results showed loss of 20 cents a share, which slightly beat estimates. Its sales ...
Long-suffering biotech investors might be in for a treat as the SPDR S&P Biotech exchange begins to show signs of renewed strength.
Biopharma stock Sarepta Therapeutics Inc (NASDAQ:SRPT) is soaring today, up 20.6% at $22.17 at last glance. The biopharmaceutical company announced a strategic restructuring plan, laying off about 500 ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
If you have $1,000 to invest right now, you may be wondering where to get started. You could buy stocks that are flying high ...
Should Investors Be Watching these Top Biotech Stocks Right Now?As we approach the end of 2021, it seems that biotech stocks could continue to make viable plays in the stock market. This can be ...
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter: MoonLake ...
4 Biotech Stocks For Your Watchlist This WeekBiotechnology stocks, also known as biotech stocks, are shares in publicly traded companies that are involved in the medical and agricultural ...
The move higher in biotech stocks comes after a rough start in the first half of the year, when the biotech index lost 17.7%, more than it lost in the first six months of any year since 2016.
Glenmark Pharmaceuticals Ltd.’s licensing pact with AbbVie Inc. for its blood cancer drug is boosting optimism over Indian ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results